title: Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells.
abstract: The recently described hepatic cell line HepaRG is the sole hepatoma cell line susceptible to hepatitis B virus (HBV) infection. It provides a unique tool for investigating some unresolved issues of the virus' biology, particularly the formation of the viral mini-chromosome believed to be responsible for the persistence of infection. In this study, we characterized the main features of HBV infection: it is restricted to a subpopulation of differentiated hepatocyte-like cells that express albumin as a functional marker and represents around 10 % of all differentiated HepaRG cells. Infection may persist for more than 100 days in cells maintained at the differentiated state. Even though infected cells continued to produce infectious viral particles, very limited or no spreading of infection was observed. Low genetic variation was also observed in the viral DNA from viruses found in the supernatant of infected cells, although this cannot explain the lack of reinfection. HBV infection of HepaRG cells appears to be a very slow process: viral replication starts at around day 8 post-infection and reaches a maximum at day 13. Analysis of viral DNA showed slow and inefficient conversion of the input relaxed circular DNA into covalently closed circular (CCC) DNA, but no further amplification. Continuous lamivudine treatment inhibited viral replication, but neither prevented viral infection nor initial formation of CCC DNA. In conclusion, HBV infection in differentiated HepaRG cells is characterized by long-term persistence without a key feature of hepadnaviruses, the so-called 'CCC DNA amplification' described in the duck hepatitis B model.
authors.affiliation: INSERM, U871, 69003 Lyon, France. olivier.hantz@inserm.fr
authors.forename: O
authors.initials: O
authors.lastname: Hantz
authors.forename: R
authors.initials: R
authors.lastname: Parent
authors.forename: D
authors.initials: D
authors.lastname: Durantel
authors.forename: P
authors.initials: P
authors.lastname: Gripon
authors.forename: C
authors.initials: C
authors.lastname: Guguen-Guillouzo
authors.forename: F
authors.initials: F
authors.lastname: Zoulim
mesh_terms: D045744:Cell Line, Tumor; D004270:DNA, Circular / Q000378:metabolism*; D004279:DNA, Viral / Q000378:metabolism*; D006515:Hepatitis B virus / Q000502:physiology*; D022781:Hepatocytes / Q000821:virology; D006801:Humans; D014779:Virus Replication
chemical_list: D004270:DNA, Circular; D004279:DNA, Viral